Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ONEOK Inc. Common Stock (OKE) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

ONEOK Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

ONEOK Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? ONEOK Inc. Common Stock trades at $91.78 (market cap $58.87B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: ONEOK Inc. Common Stock is far larger — about 32.7× Vir Biotechnology Inc. Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.58% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ONEOK Inc. Common Stock for 5 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

OKEVIR
Market Cap
$58.87B$1.80B
Volume
2,504,0541,782,836
Sector
EnergyHealth
52-Week High
$97.51$11.78
52-Week Low
$64.31$5.12
Typical Hold Time
5 Days0 Days
Enterprise Value
$91.73B$1.36B
Dividend Yield
4.58%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ONEOK Inc. Common Stock

ONEOK (OKE) trades at $93.38, up 1.48% with a bullish technical outlook and strong fundamental performance. The stock shows solid valuation metrics with P/E of 16.13 and P/S of 1.5, supported by $33.63B revenue and $3.39B net income in 2025. Recent acquisition of Brazos Midstream's assets for $4.425B expands Permian Basin presence, while quarterly dividends remain steady at $1.07 per share.

Outlook remains positive with analyst consensus target of $98.55 (5.5% upside) and no sell ratings. Key risks include integration of recent acquisition and commodity price exposure. Earnings beat expectations in 2 of last 3 quarters, with Q3 2026 results due October 27 providing next catalyst.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OKE

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About ONEOK Inc. Common Stock

ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.

Read more on OKE →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →